Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFER-SCAD: Statin and ACE Inhibitor in SCAD
NCT02008786Phase 4Terminated
- Sponsor
- UBC Division of Cardiology
- Start
- Jun 2014
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin, ramipril in spontaneous coronary artery dissection (SCAD), sponsored by UBC Division of Cardiology. Started Jun 2014; status: terminated.
02
Drugs
rosuvastatinramipril
03
Conditions
spontaneous coronary artery dissection (SCAD)
Beyond the preview
Go deeper on NCT02008786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008786.